-
Published21/03/2024
-
Deadline05/04/2024
-
Canceled12/04/2024
-
Today18/09/2026
Utilities
- indicates text translated automatically in your browsing language
Concentrate of coagulation agent IX (humidular or recombinant), parts of: 1÷2
The subject of the contract is the supply of coagulation factor IX concentrate (or recombinant) – hereinafter “coagulation factor”, in order to safeguard the continuity of treatment of patients with haemophilia type B.
https://zzpprzymz.ezamawiajacy.pl/servlet/HomeServlet
https://zzpprzymz.ezamawiajacy.pl/servlet/HomeServlet
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.